Detalhe da pesquisa
1.
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Blood
; 140(5): 491-503, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476848
2.
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis.
Blood
; 140(20): 2101-2112, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877996
3.
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma.
Blood
; 137(19): 2621-2633, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512407
4.
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma.
Haematologica
; 106(4): 978-986, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327504
5.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
6.
Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy.
Br J Haematol
; 189(2): 313-317, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804715
7.
Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations.
Am J Hematol
; 99(6): 1196-1200, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546371
8.
CAR T-cell hematotoxicity: is inflammation the key?
Blood
; 138(24): 2447-2448, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914831
9.
Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia.
Am J Hematol
; 90(5): E77-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25651001
10.
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 30(2): 229.e1-229.e11, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952648
11.
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
Clin Lymphoma Myeloma Leuk
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429222
12.
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.
Blood Cancer Discov
; 5(2): 106-113, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194367
13.
Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease.
Transplant Cell Ther
; 29(9): 577.e1-577.e9, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355201
14.
Feasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation.
Technol Cancer Res Treat
; 22: 15330338231180779, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287260
15.
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study.
Cardiooncology
; 9(1): 18, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005652
16.
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Sci Adv
; 9(38): eadg3919, 2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738350
17.
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Blood Adv
; 7(16): 4247-4257, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307173
18.
Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 28(4): 185.e1-185.e7, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017119
19.
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.
Transplant Cell Ther
; 28(12): 829.e1-829.e8, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174934
20.
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease.
Blood Adv
; 6(1): 259-269, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649279